751 The safety and efficacy of viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naïve patients infected with HCV: Phase 3 results
Open Access
- 30 April 2006
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S273
- https://doi.org/10.1016/s0168-8278(06)80739-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: